NFKB1 and COVID-19: These cell experiments verified the results of our bioinformatics analysis; namely, the active ingredient of tea, ECGC, can directly act on macrophages in the cytokine storm environment of COVID-19, and inhibit the secretion of inflammatory factors and the activation of the MAPK and NF-κB signaling pathways, improving the prognosis of COVID-19.